United States

People: Insulet Corp (PODD.O)

PODD.O on Nasdaq

9:52am EDT
Change (% chg)

$-0.71 (-0.59%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Petrovic, Shacey 

Ms. Shacey Petrovic has been appointed President, Chief Executive Officer, Director effective January 1, 2019. Ms. Petrovic served as our Executive Vice President and President, Diabetes Products, and from February 2015 to February 2016, she served as our Chief Commercial Officer. From 2013 to 2015, Ms. Petrovic served as President and Chief Executive Officer of Clinical Innovations, LLC, a developer and manufacturer of medical devices and diagnostics for women’s health. From 2000 to 2013, Ms. Petrovic served in a number of key roles at Hologic, Inc. and Cytyc Corporation, which merged with Hologic in October 2007, including Vice President and General Manager of Hologic’s GYN Surgical Products division, as well as various sales and marketing leadership roles in the U.S. and Europe. Prior to joining Cytyc Corporation, Ms. Petrovic served as a Pharmaceutical Sales Specialist at AstraZeneca. Ms. Petrovic earned her Bachelor of Science in Biology from the University of Wisconsin.

Basic Compensation

Total Annual Compensation, USD 1,397,310
Restricted Stock Awards, USD 1,625,000
Long-Term Incentive Plans, USD --
All Other, USD 633,100
Fiscal Year Total, USD 3,655,410

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --